Sir Philip Cohen to be inducted into National Academy of Sciences for groundbreaking work in biochemistry and biology
WASHINGTON, April 22 /PRNewswire/ -- Sir Philip Cohen of Scotland's University of Dundee will be inducted into the U.S. National Academy of Sciences (NAS) during its 146th annual meeting on Saturday, April 25 at 8:00 p.m. at the NAS building for his excellence in original scientific research. Sir Philip is one of only four Scottish scientists ever inducted into the NAS, one of the highest honors given to a scientist or engineer in the United States and a rare honor for non-U.S. scientists.
As Director of the MRC Protein Phosphorylation Unit and the Scottish Institute for Cell Signalling at the University of Dundee, Sir Philip has advanced the field of biochemistry. In particular, he has studied abnormal protein phosphorylation as a cause or consequence of cancer, diabetes and inflammatory disease. Under Sir Philip's direction, scientists have identified new proteins as targets for a number of breakthrough therapies today, as well as new diabetes and cancer drugs in development. For instance, protein kinase inhibitors have been approved for clinical use as anti-cancer agents, including Gleevec, a drug that has helped turn a previously fatal form of leukemia into a manageable disease.
Sir Philip's contribution to the field of life sciences is demonstrated by his longstanding commitment to collaboration across the industry. Recently, Sir Philip helped identify the Ubiquitin Proteasome System (UPS) as a promising new source for key drug targets and is part of a global UPS research program partnering life sciences company Millipore with the Universities of Glasgow, Strathclyde and Edinburgh, and Mount Sinai Hospital in Toronto.
"I believe this recognition is a testament to Scotland's longstanding commitment to advancing cutting-edge disease research, as welPage: 1 2 Related biology technology :1
. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems2
. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States3
. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom4
. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider5
. Biomira Announces Plan to Reincorporate in the United States6
. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States7
. InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom8
. United BioSource Acquires Caro Research, Leader in Simulation Modeling9
. ThalesNano Inc. Opens Own Representation in the United Kingdom and has New Distribution Agreements for Europe and India10
. ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by the United States Patent Office11
. Bioponic Phytoceuticals to Roll Out Multiple Products to 1,000 Major Health Food Stores in the Western United States